Akura Receives IDE Approval for QUADRA-PE Pivotal Trial of Katana System – Endovascular Today
November 8, 2024—Akura Medical, a Shifamed portfolio company focused on venous thromboembolism care, announced recently that the FDA has approve
November 8, 2024—Akura Medical, a Shifamed portfolio company focused on venous thromboembolism care, announced recently that the FDA has approve
BackgroundIntracerebral hemorrhage (ICH) in young adults demands greater attention, given its poor prognosis; however, there has been a paucity of epidemiological data. The objective of…
The use of 50+ year-old donors for heart transplant (HT) is rare in the United States. We assessed reasons for this—and whether it reflects concern about…
A 17-year-old male was referred for evaluation by Pediatric Cardiology following a pre-sports medical screening, which revealed abnormal ventricular repola
The American Junior Investigator Association is an organization dedicated to advocacy, career development, and mentorship to optimize the success of diverse early-career physician-scientists to contribute…
WEDNESDAY, Nov. 6, 2024 (HealthDay News) — For patients with symptomatic and severe tricuspid regurgitation (TR), tricuspid transcatheter edge-to-edge repair (
The availability of cardiac myosin inhibitors (CMI) to treat symptomatic left ventricular outflow tract obstruction (LVOTO) and the evolving recommendation
BACKGROUND: Mitral annular calcification with valve dysfunction remains a challenging syndrome. Operative risk is high, and available transcatheter therapies are limited. METHODS: This study describes…
The novel GLP-1 receptor agonists will likely reduce the need for CABG and improve surgical outcomes, several argue.
Large language models (LLMs) have gained considerable attention for the potential to make medical knowledge more accessible to patients, particularly for answering patient questions. 1…